Sign In

Login

Password

Forgot Password ? Sign Up

쿠쿠르비타신 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "쿠쿠르비타신" in Korean language version.

refsWebsite
Global rank Korean rank
6nih.gov
4th place
4th place
5doi.org
2nd place
3rd place
3web.archive.org
1st place
1st place
1eikanken-okinawa.jp
low place
low place
1nhk.or.jp
145th place
528th place
1ajoumc.or.kr
low place
low place
1spandidos-publications.com
low place
low place

ajoumc.or.kr

hosp.ajoumc.or.kr

doi.org

dx.doi.org

  • Kapoor, S (2013). “Cucurbitacin B and Its Rapidly Emerging Role in the Management of Systemic Malignancies Besides Lung Carcinomas”. Cancer biotherapy & radiopharmaceuticals 28 (4): 359. doi:10.1089/cbr.2012.1373. PMID 23350897. 
  • Ishii, T; Kira, N; Yoshida, T; Narahara, H (2013). “Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells”. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 34 (1): 285–91. doi:10.1007/s13277-012-0549-2. PMID 23150173. 
  • Lui, VW; Yau, DM; Wong, EY; Ng, YK; Lau, CP; Ho, Y; Chan, JP; Hong, B; Ho, K; Cheung, CS; Tsang, CM; Tsao, SW; Chan, AT (2009). “Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells”. Carcinogenesis 30 (12): 2085–94. doi:10.1093/carcin/bgp253. PMID 19843642. 
  • Sun, J; Blaskovich, MA; Jove, R; Livingston, SK; Coppola, D; Sebti, SM (2005). “Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity”. Oncogene 24 (20): 3236–45. doi:10.1038/sj.onc.1208470. PMID 15735720. 

doi.org

eikanken-okinawa.jp

nhk.or.jp

www3.nhk.or.jp

nih.gov

ncbi.nlm.nih.gov

  • [참고](Int J Health Sci (Qassim). 2013 Jan; 7(1): 77–89.doi: 10.12816/0006025 PMCID: PMC3612419 PMID: 23559908 Cucurbitacins – A Promising Target for Cancer Therapy Dr. Abdullah A. Alghasham)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612419/
  • Alghasham, AA (2013). “Cucurbitacins - a promising target for cancer therapy”. International journal of health sciences 7 (1): 77–89. PMC 3612419. PMID 23559908. 
  • Kapoor, S (2013). “Cucurbitacin B and Its Rapidly Emerging Role in the Management of Systemic Malignancies Besides Lung Carcinomas”. Cancer biotherapy & radiopharmaceuticals 28 (4): 359. doi:10.1089/cbr.2012.1373. PMID 23350897. 
  • Ishii, T; Kira, N; Yoshida, T; Narahara, H (2013). “Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells”. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 34 (1): 285–91. doi:10.1007/s13277-012-0549-2. PMID 23150173. 
  • Lui, VW; Yau, DM; Wong, EY; Ng, YK; Lau, CP; Ho, Y; Chan, JP; Hong, B; Ho, K; Cheung, CS; Tsang, CM; Tsao, SW; Chan, AT (2009). “Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells”. Carcinogenesis 30 (12): 2085–94. doi:10.1093/carcin/bgp253. PMID 19843642. 
  • Sun, J; Blaskovich, MA; Jove, R; Livingston, SK; Coppola, D; Sebti, SM (2005). “Cucurbitacin Q: A selective STAT3 activation inhibitor with potent antitumor activity”. Oncogene 24 (20): 3236–45. doi:10.1038/sj.onc.1208470. PMID 15735720. 

spandidos-publications.com

web.archive.org